Evidence map›Paper›PMID 36684440›Full record

ArticleFrontiers in cell and developmental biology2022

Designing of SiO

Yasir Mehmood, Hira Shahid, Kashif Barkat, Muhammad Ibraheem, Humayun Riaz, Syed Faisal Badshah, Hitesh Chopra, Rohit Sharma, Eugenie Nepovimova, Kamil Kuca and 2 more

RetractedAbstract readRetracted Publication
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

  • Retraction · 2024-12-13Concerns/Issues about Image · Concerns/Issues about Results and/or Conclusions · Investigation by Journal/Publisher · Objections by Author(s) · · see also: https://pubpeer.com/publications/3C7439FB742521CDC3AA7189A49905
  • Retracted
5 · Who and what money

Authors and funding

12 authors.

Yasir MehmoodRiphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University Faisalabad, Faisalabad, Pakistan.
Hira ShahidSaffron Pharmaceuticals (Pvt.) Ltd., Faisalabad, Pakistan.
Kashif BarkatFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Muhammad IbraheemRiphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University Faisalabad, Faisalabad, Pakistan.
Humayun RiazRashid Latif College of Pharmacy, Rashid Latif Khan University, Lahore, Pakistan.
Syed Faisal BadshahFaculty of Pharmacy, University of Lahore, Lahore, Pakistan.
Hitesh ChopraChitkara College of Pharmacy, Chitkara University, Chandigarh, Punjab, India.
Rohit SharmaDepartment of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Eugenie NepovimovaDepartment of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czechia.
Kamil KucaDepartment of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czechia.
Martin ValisDepartment of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital, Hradec Králové, Czechia.
Talha Bin EmranDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main objective of the current research work was to synthesize mesoporous silica nanoparticles for controlled delivery of mometasone furoate for potential nasal delivery. The optimized sol-gel method was used for the synthesis of mesoporous silica nanoparticles. Synthesized nanoparticles were processed through Zeta sizer, SEM, TEM, FTIR, TGA, DSC, XRD, and BET analysis for structural characterization. The

Indexed as

controlled releasedrug deliveryex vivo studymesoporous silica nanoparticlesnasal spray

Identifiers

PMID36684440
PMCPMC9853011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.